Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
acquisition tags : Therapeutics save search
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
IPSC | $2.98 -4.79% -5.03% 130K
|
Professional, Scientific, and T...
|
| O: 3.39%
H: 11.53%
C: 2.02%
disease million pipeline acquisition expansion therapeutics
Nuvation Bio Completes Acquisition of AnHeart Therapeutics
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
NUVB | $2.66 -0.75% 0.0% 990K
|
|
| O: -4.64%
H: 1.3%
C: -0.97%
acquisition therapeutics
Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 21:00) - globenewswire.com
JSPR | $22.08 -0.14% -0.14% 45K
|
|
| O: 5.76%
H: 4.44%
C: -2.2%
conference therapeutics
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
Published: 2024-03-25 (Crawled : 14:00) - biospace.com/
NUVB | $2.66 -0.75% 0.0% 990K
|
|
| O: -15.8%
H: 24.94%
C: 15.68%
acquire therapeutics
LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress
Published: 2024-03-21 (Crawled : 22:00) - biospace.com/
VIRX | $0.8367 -1.31% -1.33% 55K
|
Manufacturing
|
| O: 0.88%
H: 2.63%
C: -6.14%
update therapeutics
Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
Published: 2024-03-21 (Crawled : 21:00) - globenewswire.com
JSPR | $22.08 -0.14% -0.14% 45K
|
|
| O: 1.31%
H: 0.35%
C: -2.76%
conference disease therapeutics
Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria
Published: 2024-03-19 (Crawled : 12:00) - globenewswire.com
JSPR | $22.08 -0.14% -0.14% 45K
|
|
| O: -1.29%
H: 9.86%
C: 6.93%
first urticaria therapeutics study
Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion
Published: 2024-03-18 (Crawled : 15:30) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.46%
H: 0.23%
C: -1.88%
acquisition therapeutics
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing
Published: 2024-03-18 (Crawled : 11:00) - globenewswire.com
PPRUF | News | $340.0 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -0.49%
H: 2.65%
C: 2.65%
PPRUY | News | $33.79 -0.11% 360K
|
Manufacturing
|
| O: -0.43%
H: 0.02%
C: -0.5%
PHGE | $0.3274 -5.51% 3.82% 130K
|
Health Technology
|
| O: 1.09%
H: 3.38%
C: -2.7%
million acquisition therapeutics
Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments
Published: 2024-03-04 (Crawled : 17:00) - biospace.com/
JSPR | $22.08 -0.14% -0.14% 45K
|
|
| O: 6.79%
H: 0.0%
C: -5.51%
therapeutics financial results
Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference
Published: 2024-02-26 (Crawled : 22:00) - globenewswire.com
JSPR | $22.08 -0.14% -0.14% 45K
|
|
| O: 1.3%
H: 5.45%
C: -0.19%
conference therapeutics
Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Published: 2024-02-23 (Crawled : 13:00) - globenewswire.com
JSPR | $22.08 -0.14% -0.14% 45K
|
|
| O: -0.82%
H: 7.48%
C: 5.2%
preclinical immunology meeting therapeutics
Phoenix Biotech Acquisition Closes CERo Therapeutics Deal
Published: 2024-02-15 (Crawled : 15:30) - spacfeed.com
SCRM S | $10.785 0.14% 0.14% 69K
|
n/a
|
| O: 0.19%
H: 0.0%
C: -0.19%
biotech acquisition deal therapeutics
Swiftmerge Mutually Terminates HDL Therapeutics Deal
Published: 2024-02-15 (Crawled : 14:30) - spacfeed.com
SCRM S | $10.785 0.14% 0.14% 69K
|
n/a
|
| O: 0.19%
H: 0.0%
C: -0.19%
deal therapeutics
Phoenix Biotech Acquisition Boosts Earnout Shares for CERo Therapeutics
Published: 2024-02-14 (Crawled : 21:00) - spacfeed.com
SCRM S | $10.785 0.14% 0.14% 69K
|
n/a
|
| O: 0.19%
H: 0.0%
C: -0.19%
CBRG | $11.24 0.0% 6
|
n/a
|
| O: -1.61%
H: 1.38%
C: 1.38%
biotech acquisition therapeutics
Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics
Published: 2024-02-12 (Crawled : 14:30) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.35%
H: 2.36%
C: 1.42%
CBAY | $32.48 0.03% 8.4M
|
Health Technology
|
| O: 27.92%
H: 0.97%
C: 0.88%
liver acquisition sciences therapeutics
Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference
Published: 2024-02-07 (Crawled : 13:00) - globenewswire.com
JSPR | $22.08 -0.14% -0.14% 45K
|
|
| O: 14.16%
H: 6.26%
C: 3.37%
conference therapeutics
Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock
Published: 2024-02-06 (Crawled : 14:00) - globenewswire.com
JSPR | $22.08 -0.14% -0.14% 45K
|
|
| O: 11.04%
H: 12.56%
C: 3.13%
million offering therapeutics
Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Published: 2024-02-05 (Crawled : 13:00) - globenewswire.com
JSPR | $22.08 -0.14% -0.14% 45K
|
|
| O: 0.17%
H: 12.78%
C: 7.47%
preclinical immunology meeting therapeutics
Jasper Therapeutics Highlights Recent Accomplishments and Key Upcoming Milestones
Published: 2024-01-05 (Crawled : 13:30) - globenewswire.com
JSPR | $22.08 -0.14% -0.14% 45K
|
|
| O: 0.0%
H: 0.85%
C: 0.57%
therapeutics
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.